Neonc Technologies (NASDAQ:NTHI) Stock Rating Lowered by Wall Street Zen

Neonc Technologies (NASDAQ:NTHI) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday.

NTHI has been the subject of several other reports. Maxim Group initiated coverage on shares of Neonc Technologies in a research report on Monday, May 18th. They set a “buy” rating and a $20.00 price objective for the company. Weiss Ratings lowered Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, June 24th. Alliance Global Partners started coverage on Neonc Technologies in a report on Tuesday, May 19th. They issued a “buy” rating and a $13.00 target price on the stock. Finally, BTIG Research restated a “buy” rating and issued a $15.00 price target on shares of Neonc Technologies in a research note on Tuesday, May 26th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $16.00.

Neonc Technologies Stock Performance

Shares of Neonc Technologies stock opened at $4.22 on Friday. Neonc Technologies has a 52-week low of $3.01 and a 52-week high of $12.99. The company has a 50 day moving average of $4.11 and a 200 day moving average of $6.08.

Neonc Technologies (NASDAQ:NTHI) last posted its quarterly earnings results on Friday, August 14th. The company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.46).

Institutional Trading of Neonc Technologies

Several institutional investors have recently modified their holdings of the stock. Barclays PLC boosted its holdings in shares of Neonc Technologies by 5,314.8% in the 4th quarter. Barclays PLC now owns 9,151 shares of the company’s stock valued at $76,000 after buying an additional 8,982 shares in the last quarter. Goldman Sachs Group Inc. acquired a new stake in Neonc Technologies during the 4th quarter worth $124,000. Global Retirement Partners LLC purchased a new stake in Neonc Technologies in the second quarter valued at $126,000. OMERS ADMINISTRATION Corp acquired a new position in Neonc Technologies in the fourth quarter valued at $126,000. Finally, Royal Bank of Canada acquired a new position in Neonc Technologies in the first quarter valued at $247,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.